Jeff Mortensen is a 15 year veteran developing and distributing vision screening technology to pediatric primary care, eye care, charitable and education markets.
Inspired by Rebion's "Neural Performance Scanning" technology and the opportunity for the amblyopia screening market to make a major leap forward in detecting disease, Jeff joined Rebion's commercialization team as their vision scanning technology received FDA clearance in 2016.
Jeff and his team are revitalizing awareness of the importance of amblyopia screening initiatives in primary care by delivering a device that yields unprecedented accuracy.
You may recognize the Rebion sales team from a company called "PediaVision." This core group led the broad expansion of instrument-based vision screening from 2007 to 2014.